Northwestern University Feinberg School of Medicine physicians are leading the way in researching innovative new therapies for people with type 2 diabetes who are obese. In Illinois, 1.4 million people have diabetes, and more than 1.1 million of these people live in the Chicago-area, according to the CDC.
Why now? This month the CDC released the latest diabetes stats.CDC Diabetes Stats 2014 (29.1 million people in the U.S. have diabetes) and The annual American Diabetes Association meeting (ADA) begins this weekend and the news coming out so far look like there will be a larger focus on the role of obesity in diabetes.
What is the new research happening at Northwestern? It’s a non-surgical device designed to treat diabetes and obesity and they need local Chicago-area residents who have type 2 diabetes who are obese to contact them to get information about the trial.
How does it work? A thin, flexible, tube-shaped liner (called the EndoBarrier) is placed via the mouth during a brief endoscopic procedure. It’s designed to change the way the body responds to food, by altering the release gut hormones. This may help reduce appetite and improve the body’s ability to control blood sugar. Animation depicting placement and how it works can be found here.
Chicago area residents with type 2 diabetes who are obese can get more information about participating in the trial at http://www.endobarriertrial.com or call 1-888-9STUDY9 (1-888-978-8399).
The EndoBarrier device is made by Lexington, Mass., based GI Dynamics and has been widely approved internationally since 2010 and is currently available in Chile, Australia, and a growing number of countries in Europe and the Middle East.